Mutant MHC class II epitopes drive therapeutic immune responses to cancer S Kreiter, M Vormehr, N Van de Roemer, M Diken, M Löwer, J Diekmann, ... Nature 520 (7549), 692-696, 2015 | 1284 | 2015 |
Exploiting the mutanome for tumor vaccination JC Castle, S Kreiter, J Diekmann, M Löwer, N Van de Roemer, J de Graaf, ... Cancer research 72 (5), 1081-1091, 2012 | 928 | 2012 |
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma JC Castle, M Loewer, S Boegel, J de Graaf, C Bender, AD Tadmor, ... BMC genomics 15, 1-12, 2014 | 379 | 2014 |
HLA typing from RNA-Seq sequence reads S Boegel, M Löwer, M Schäfer, T Bukur, J De Graaf, V Boisguérin, ... Genome medicine 4, 1-12, 2013 | 291 | 2013 |
Multi-omics characterization of the 4T1 murine mammary gland tumor model B Schrörs, S Boegel, C Albrecht, T Bukur, V Bukur, C Holtsträter, C Ritzel, ... Frontiers in oncology 10, 1195, 2020 | 141 | 2020 |
HLA and proteasome expression body map S Boegel, M Löwer, T Bukur, P Sorn, JC Castle, U Sahin BMC medical genomics 11, 1-12, 2018 | 115 | 2018 |
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines S Boegel, M Löwer, T Bukur, U Sahin, JC Castle Oncoimmunology 3 (8), e954893, 2014 | 111 | 2014 |
Mutanome directed cancer immunotherapy M Vormehr, M Diken, S Boegel, S Kreiter, U Sahin Current Opinion in Immunology 39, 14-22, 2016 | 74 | 2016 |
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression J Scholtalbers, S Boegel, T Bukur, M Byl, S Goerges, P Sorn, M Loewer, ... Genome medicine 7, 1-7, 2015 | 68 | 2015 |
Mutated tumor alleles are expressed according to their DNA frequency JC Castle, M Loewer, S Boegel, AD Tadmor, V Boisguerin, J de Graaf, ... Scientific reports 4 (1), 4743, 2014 | 53 | 2014 |
Mutanome engineered RNA immunotherapy: towards patient-centered tumor vaccination M Vormehr, B Schrörs, S Boegel, M Löwer, Ö Türeci, U Sahin Journal of Immunology Research 2015, 2015 | 43 | 2015 |
MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection DV Rozanov, ND Rozanov, KE Chiotti, A Reddy, PA Wilmarth, LL David, ... Journal of proteomics 176, 13-23, 2018 | 35 | 2018 |
Bioinformatic methods for cancer neoantigen prediction S Boegel, JC Castle, J Kodysh, T O'Donnell, A Rubinsteyn Progress in molecular biology and translational science 164, 25-60, 2019 | 29 | 2019 |
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells F Foerster, S Boegel, R Heck, G Pickert, N Rüssel, S Rosigkeit, M Bros, ... Oncoimmunology 7 (4), e1409929, 2018 | 27 | 2018 |
Predicting immunogenicity of T cell epitopes U Sahin, AD Tadmor, JC Castle, S Boegel, M Löwer US Patent 11,222,711, 2022 | 22 | 2022 |
In silico HLA typing using standard RNA-Seq sequence reads S Boegel, J Scholtalbers, M Löwer, U Sahin, JC Castle Molecular Typing of Blood Cell Antigens, 247-258, 2015 | 19 | 2015 |
In silico typing of classical and non-classical HLA alleles from standard RNA-Seq reads S Boegel, T Bukur, JC Castle, U Sahin HLA Typing: Methods and Protocols, 177-191, 2018 | 7 | 2018 |
Bioinformatics for Cancer Immunotherapy: Methods and Protocols S Boegel Humana Press, 2020 | 6 | 2020 |
Definitive evidence for Club cells as progenitors for mutant Kras/Trp53deficient lung cancer S Rosigkeit, M Kruchem, D Thies, A Kreft, E Eichler, S Boegel, S Jansky, ... International journal of cancer 149 (9), 1670-1682, 2021 | 5 | 2021 |
HLA typing S Boegel Methods in Molecular Biology, 2018 | 4 | 2018 |